28 results
PRE 14A
LBPH
Longboard Pharmaceuticals Inc
28 Mar 24
Preliminary proxy
4:36pm
, since October 2020. Dr. Kaye earned an M.D., M.P.H. and B.S. at George Washington University, completed his pediatric training at UMASS Medical Center … and finished his academic training as a postdoctoral Research Fellow at Harvard Medical School.
EXECUTIVE COMPENSATION
Our named executive officers
8-K
EX-99.1
0llfv t9ptb
3 Nov 22
Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2022 Financial Results
8:46am
DEF 14A
1mw7sbxjlxn60
13 Apr 22
Definitive proxy
4:15pm
10-K
l1yv 2v8rpkupv
3 Mar 22
Annual report
4:31pm
10-Q
l35k 6yptk
10 May 21
Quarterly report
4:45pm
424B4
d1z8t
12 Mar 21
Prospectus supplement with pricing info
5:02pm
S-1/A
EX-10.12
ci3lbqx5scycjyid4dx3
8 Mar 21
IPO registration (amended)
6:13am